Effectiveness of a fourth SARS-CoV-2 vaccine dose in previously infected individuals from Austria,European Journal of Clinical Investigation

当前位置： X-MOL 学术 › Eur. J. Clin. Investig. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Effectiveness of a fourth SARS-CoV-2 vaccine dose in previously infected individuals from Austria
European Journal of Clinical Investigation ( IF 4.4 ) Pub Date : 2023-11-30 , DOI: 10.1111/eci.14136
Alena Chalupka ₁ , Lukas Richter _{1,

2} , Ali Chakeri _{1,

3} , Ziad El-Khatib ₁ , Verena Theiler-Schwetz ₄ , Christian Trummer ₄ , Robert Krause ₅ , Peter Willeit _{6,

7,

8} , Bernhard Benka ₁ , John P A Ioannidis ₉ , Stefan Pilz ₄

Affiliation

Evidence is limited on the effectiveness of a fourth vaccine dose against coronavirus disease 2019 (COVID-19) in populations with prior severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. We estimated the risk of COVID-19 deaths and SARS-CoV-2 infections according to vaccination status in previously infected individuals in Austria.

中文翻译：

第四剂 SARS-CoV-2 疫苗对奥地利既往感染者的有效性

关于第四剂疫苗对既往严重急性呼吸系统综合症冠状病毒 2 （SARS-CoV-2）感染人群的 2019 冠状病毒病（COVID-19）的有效性证据有限。我们根据奥地利既往感染者的疫苗接种状态估计了 COVID-19 死亡和 SARS-CoV-2 感染的风险。

更新日期：2023-11-30

点击分享查看原文

点击收藏

公开下载

阅读更多本刊新发论文本刊介绍/投稿指南